Latest News

Read the latest updates from Quotient Sciences.
Quotient Sciences Wins 2025 CDMO Leadership Awards
Awards & Recognition

Quotient Sciences Recognized as a Winner of 2025 CDMO Leadership Awards

Read More

21 - 25 of 155 results

Manufacturing Chemist
Articles & Publications, Events, Dr. Andrew Lewis, Dr. Andrew Parker, Formulation Development, GLP-1 Therapeutics, Oral PeptidesVideo Interview: Dr. Andrew Lewis and Dr. Andrew Parker Speak with Manufacturing Chemist at CPHI Milan
Articles & Publications, Events, Dr. Andrew Lewis, Dr. Andrew Parker, Formulation Development, GLP-1 Therapeutics, Oral PeptidesVideo Interview: Dr. Andrew Lewis and Dr. Andrew Parker Speak with Manufacturing Chemist at CPHI Milan

In this video interview with Manufacturing Chemist, Dr. Andrew Lewis, Chief Scientific Officer, and Dr. Andrew Parker, Senior Drug Development Consultant, discussed the growing interest in oral peptides and common challenges faced in precli...

Learn more

New preclinical technology screening service available to support clients through earlier stages of drug development.

Learn more

“Quotient Sciences is the first CDMO to successfully install and qualify the GMP Biofoundary-in-a-Box system. We’re delighted to be working with them to enable the development of new RNA-based therapies and accelerate the delivery of existi...

Learn more

Martin discusses streamlined formulation strategy, benefits of simplified formulation, and why working together with experts is key a to accelerating FiH trials.

Learn more

The Fierce CRO Awards celebrate exceptional achievements and innovations by Contract Research Organizations (CROs).

Learn more
Upcoming Events
Schedule a meeting with us at an upcoming industry event.